ANEBULO PHARMACEUTICALS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-4.9M | $-4.9M | — | $199.9K |
| FY2022 | $-5.4M | $-5.4M | — | $480.7K |
| FY2023 | $-9.7M | $-9.7M | — | $884.7K |
| FY2024 | $-8.1M | $-8.1M | — | $758.9K |
| FY2025 | $-6.3M | $-6.3M | — | $1.4M |